MDPHP (3',4'-Methylenedioxy-α-pyrrolidinohexiophenone) is a stimulant of the cathinone class originally developed in the 1960s,[1] which has been reported as a novel designer drug. In the UK its slang name is monkey dust.[2][3] It is closely related to the potent stimulant MDPV though with slightly milder effects, and has been used as an alternative in some countries following the banning of MDPV.[4][5][6][7]
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C17H23NO3 |
Molar mass | 289.375 g·mol−1 |
3D model (JSmol) | |
| |
|
Pharmacology
editMDPHP acts as a potent norepinephrine-dopamine reuptake inhibitor. The IC50 values for MDPHP are 0.06 μM at NET, 0.05 μM at DAT and 9 μM at SERT.[8]
Legal status
editMDPHP is specifically listed as a controlled substance in Japan [9] and Hungary,[10] and is controlled under analogue provisions in a number of other jurisdictions.
Documented fatalities
editA case of a "fatal acute intoxication caused by MDPHP" in a 48 year old male was reported in February 2022 by physicians at an Italian hospital.[11] Another case has been reported, involving a 30-years-old male cocaine consumer, found dead on July 20th, 2023, in Florence, Italy; MDPHP and alpha-PHP were the only psychoactive substance found. [12]
See also
editReferences
edit- ^ DE 1545591, Koeppe H, Zeile K, Ludwig G, "Patent DE - Verfahren zur Herstellung von α-Aminoketonen mit heterocyclischer Aminogruppe", issued 28 May 1965
- ^ "Monkey Dust drug use 'an epidemic', emergency workers warn". BBC. 10 August 2018. Retrieved 16 August 2018.
- ^ Roberts M. Monkey dust drug clampdown could be coming in UK. BBC News, 11 May 2023
- ^ Zaitsu K, Katagi M, Tsuchihashi H, Ishii A (2013). "Recently abused synthetic cathinones, α-pyrrolidinophenone derivatives: A review of their pharmacology, acute toxicity, and metabolism". Forensic Toxicology. 32: 1–8. doi:10.1007/s11419-013-0218-1. S2CID 25604845.1-8&rft.date=2013&rft_id=info:doi/10.1007/s11419-013-0218-1&rft_id=https://api.semanticscholar.org/CorpusID:25604845#id-name=S2CID&rft.aulast=Zaitsu&rft.aufirst=K&rft.au=Katagi, M&rft.au=Tsuchihashi, H&rft.au=Ishii, A&rfr_id=info:sid/en.wikipedia.org:MDPHP" class="Z3988">
- ^ Kaizaki-Mitsumoto A, Noguchi N, Yamaguchi S, Odanaka Y, Matsubayashi S, Kumamoto H, et al. (January 2016). "Three 25-NBOMe-type drugs, three other phenethylamine-type drugs (25I-NBMD, RH34, and escaline), eight cathinone derivatives, and a phencyclidine analog MMXE, newly identified in ingredients of drug products before they were sold on the drug market". Forensic Toxicology. 34 (1): 108–14. doi:10.1007/s11419-015-0293-6. S2CID 45890497.108-14&rft.date=2016-01&rft_id=info:doi/10.1007/s11419-015-0293-6&rft_id=https://api.semanticscholar.org/CorpusID:45890497#id-name=S2CID&rft.aulast=Kaizaki-Mitsumoto&rft.aufirst=A&rft.au=Noguchi, N&rft.au=Yamaguchi, S&rft.au=Odanaka, Y&rft.au=Matsubayashi, S&rft.au=Kumamoto, H&rft.au=Fukuhara, K&rft.au=Funada, M&rft.au=Wada, K&rft.au=Numazawa, S&rfr_id=info:sid/en.wikipedia.org:MDPHP" class="Z3988">
- ^ Beck O, Bäckberg M, Signell P, Helander A (April 2018). "Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats". Clinical Toxicology. 56 (4). Philadelphia, Pa.: 256–263. doi:10.1080/15563650.2017.1370097. PMID 28895757. S2CID 3401681.256-263&rft.date=2018-04&rft_id=https://api.semanticscholar.org/CorpusID:3401681#id-name=S2CID&rft_id=info:pmid/28895757&rft_id=info:doi/10.1080/15563650.2017.1370097&rft.aulast=Beck&rft.aufirst=O&rft.au=Bäckberg, M&rft.au=Signell, P&rft.au=Helander, A&rft_id=https://doi.org/10.1080%2F15563650.2017.1370097&rfr_id=info:sid/en.wikipedia.org:MDPHP" class="Z3988">
- ^ Fowble KL, Shepard JR, Musah RA (March 2018). "Identification and classification of cathinone unknowns by statistical analysis processing of direct analysis in real time-high resolution mass spectrometry-derived "neutral loss" spectra". Talanta. 179: 546–553. doi:10.1016/j.talanta.2017.11.020. PMID 29310273.546-553&rft.date=2018-03&rft_id=info:doi/10.1016/j.talanta.2017.11.020&rft_id=info:pmid/29310273&rft.aulast=Fowble&rft.aufirst=KL&rft.au=Shepard, JR&rft.au=Musah, RA&rft_id=https://doi.org/10.1016%2Fj.talanta.2017.11.020&rfr_id=info:sid/en.wikipedia.org:MDPHP" class="Z3988">
- ^ Kolaczynska K, Thomann J, Hoener M, Liechti M (2021). "The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative". International Journal of Molecular Sciences. 22 (15): 8277. doi:10.3390/ijms22158277. PMC 8348686. PMID 34361040.
- ^ "指定薬物名称・構造式一覧(平成27年9月16日現在)" [List of designated drug names and structural formulas (as of September 16, 2015)] (PDF) (in Japanese). 厚生労働省 (Ministry of Health, Labour and Welfare). 16 September 2015. Retrieved 8 October 2015.
- ^ "A Daath.hu kiegészítése a BSZKI "designer jogi listáján" nem szereplő, de a C-lista 1.-4. szerkezeti leírásainak megfelelő, illetve a C-lista 5. felsorolásában szereplő néhány anyagról" [The addition to Daath.hu is not included in the "designer legal list" of the BSZKI, but C-list 1.-4. and some of the substances in list 5 of list C.] (PDF) (in Hungarian).
- ^ Di Candia D, Boracchi M, Ciprandi B, Giordano G, Zoja R (September 2022). "A unique case of death by MDPHP with no other co-ingestion: a forensic toxicology case". International Journal of Legal Medicine. 136 (5): 1291–1296. doi:10.1007/s00414-022-02799-w. PMC 9375735. PMID 35169902.1291-1296&rft.date=2022-09&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375735#id-name=PMC&rft_id=info:pmid/35169902&rft_id=info:doi/10.1007/s00414-022-02799-w&rft.aulast=Di Candia&rft.aufirst=D&rft.au=Boracchi, M&rft.au=Ciprandi, B&rft.au=Giordano, G&rft.au=Zoja, R&rft_id=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375735&rfr_id=info:sid/en.wikipedia.org:MDPHP" class="Z3988">
- ^ NEWS-D "NEWS-D_16_24_Allerta di grado 3_decesso_MDPHP" July 16th, 2024 by the National Early Warning System on Drugs